Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients

Immune checkpoint inhibitors (ICIs) are emerging as the new standard of care for treating various metastatic cancers. It is known that effective anti-tumor immune responses are associated with a stronger presence of tumor-infiltrating lymphocytes (TILs) in solid tumor tissue. Cancer patients with re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Hasan Ali, Omar, Berner, Fiamma, Ackermann, Christoph Jakob, Ring, Sandra Stephanie, Moulin, Alexandre, Müller, Joachim, Markert, Eva, Pop, Oltin Tiberiu, Müller, Stefanie, Diem, Stefan, Hundsberger, Thomas, Flatz, Lukas
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Research Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889549/
https://ncbi.nlm.nih.gov/pubmed/32804246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02693-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados